Health claim
“Benign prostatic hyperplasia (BPH) can raise prostate-specific antigen (PSA) levels.”
Claim checked — strong evidenceHigh riskcancer
Evidence Summary
Multiple well-designed studies consistently support this claim.
Benign prostatic hyperplasia commonly leads to an increase in serum PSA levels due to increased prostate volume and cellular activity, which is well-documented in clinical studies.
Extracted from
How BPH Complicates Treatment for Prostate Cancer | Mark Scholz, MD | PCRIProstate Cancer Research Institute
The video explains how benign prostatic hyperplasia (BPH) can raise PSA levels and complicate the diagnosis and treatment of prostate cancer, emphasizing the need for careful clinical assessment.
Watch breakdown →